Search results
Swiss National Bank Decreases Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
ETF DAILY NEWS· 8 hours agoSwiss National Bank decreased its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 10.2% during the 4th quarter, according to the company in its most ...
Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed...
Simply Wall St. via Yahoo Finance· 4 days agoBeam Therapeutics Inc. (NASDAQ:BEAM) shareholders are probably feeling a little disappointed, since...
Fulcrum Therapeutics Stock Climbs In Pre-market On License Deal With Sanofi For Losmapimod
RTT News· 2 hours agoShares of Fulcrum Therapeutics, Inc. (FULC) were gaining more than 16 percent in the pre-market activity on the Nasdaq after the company announced a collaboration and license ...
Need To Know: Analysts Are Much More Bullish On Repare Therapeutics Inc. (NASDAQ:RPTX)
Simply Wall St. via Yahoo Finance· 1 day agoRepare Therapeutics Inc. (NASDAQ:RPTX) shareholders will have a reason to smile today, with the...
Earnings Beat: Intellia Therapeutics, Inc. (NASDAQ:NTLA) Just Beat Analyst Forecasts, And Analysts...
Simply Wall St. via Yahoo Finance· 1 day agoIntellia Therapeutics, Inc. (NASDAQ:NTLA) just released its quarterly report and things are looking...
Checkpoint Therapeutics First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.89 loss in 1Q...
Simply Wall St. via Yahoo Finance· 23 hours agoCheckpoint Therapeutics (NASDAQ:CKPT) First Quarter 2024 Results Key Financial Results Net loss:...
Nabriva Therapeutics (NASDAQ:NBRV) Now Covered by StockNews.com
ETF DAILY NEWS· 11 hours agoInvestment analysts at StockNews.com assumed coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) in a report issued on Saturday. The brokerage set a ...
Arcturus Therapeutics Holdings First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 4 days agoArcturus Therapeutics Holdings (NASDAQ:ARCT) First Quarter 2024 Results Key Financial Results...
Knight Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 1 day agoKnight Therapeutics (TSE:GUD) First Quarter 2024 Results Key Financial Results Revenue: CA$86.6m (up...
Beam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss
Zacks via Yahoo Finance· 5 days agoBeam Therapeutics Inc. BEAM incurred a loss of $1.21 per share in the first quarter of 2024,...